Department of Internal Medicine and Charles, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8885, USA.
J Clin Endocrinol Metab. 2011 Dec;96(12):3733-40. doi: 10.1210/jc.2011-1531. Epub 2011 Oct 5.
Dietary intake of animal proteins is associated with an increase in urinary calcium and nephrolithiasis risk. We tested the hypothesis that the acid load imposed by dietary proteins causes this hypercalciuria.
In a short-term crossover metabolic study, an alkali salt was provided with a high-protein diet (HPD) to neutralize the acid load imparted by dietary proteins.
Eleven healthy volunteers were evaluated at the end of each of four phases while consuming metabolic diets with fixed calcium and sodium content. Phases 1 and 3 consisted of a control diet (CD). Phases 2 and 4 consisted of a eucaloric HPD (60 g/d animal proteins added to CD). Along with HPD in phases 2 and 4, subjects ingested 30 mEq twice daily of either potassium citrate (KCitrate, alkaline salt) or potassium chloride (KCl, control neutral salt).
KCitrate completely neutralized the acid load imparted by HPD (based on changes in urine pH and net acid excretion) and increased urinary citrate. Urinary calcium increased during both HPD phases compared with CD but was not significantly different between the HPD + KCl and HPD + KCitrate phases (182 ± 85 vs. 170 ± 85 mg/d; P = 0.28). Increased urinary saturation with respect to calcium oxalate and uric acid with HPD was abrogated by KCitrate.
This study suggests that, at least in the short-term, mechanism(s) other than acid load account for hypercalciuria induced by HPD. The beneficial effect of KCitrate on nephrolithiasis risk with HPD is through correction of declines in urine pH and citrate.
动物蛋白的饮食摄入与尿钙增加和肾结石风险增加有关。我们检验了这样一个假设,即饮食蛋白所带来的酸负荷导致了这种高钙尿症。
在一项短期交叉代谢研究中,给高蛋白饮食(HPD)提供一种碱盐,以中和饮食蛋白带来的酸负荷。
11 名健康志愿者在每个阶段结束时分别接受评估,同时摄入具有固定钙和钠含量的代谢饮食。阶段 1 和 3 包括对照饮食(CD)。阶段 2 和 4 由热量平衡的 HPD(CD 中添加 60 克/天的动物蛋白)组成。在阶段 2 和 4 中与 HPD 一起,受试者每天两次摄入 30 mEq 的柠檬酸钾(KCitrate,碱性盐)或氯化钾(KCl,对照中性盐)。
KCitrate 完全中和了 HPD 带来的酸负荷(基于尿液 pH 值和净酸排泄的变化),并增加了尿中的柠檬酸盐。与 CD 相比,HPD 期间的尿钙均增加,但 HPD+KCl 和 HPD+KCitrate 期间的尿钙没有显著差异(182±85 比 170±85mg/d;P=0.28)。HPD 引起的尿草酸和尿酸饱和度增加,被 KCitrate 所消除。
这项研究表明,至少在短期内,HPD 引起的高钙尿症的机制不仅仅是酸负荷。KCitrate 对 HPD 相关肾结石风险的有益作用是通过纠正尿液 pH 值和柠檬酸盐的下降来实现的。